Cullinan Therapeutics, Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Cullinan Therapeutics, Inc. has filed 438 SEC EDGAR filings since 02 Nov 2020

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 226-250 of 438 matching filings.

Per page

25

Current page

10

10-Q File 001-39856

10-Q

Filing date: 11 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39856

8-K

Filing date: 11 May 2023
Reporting date: 11 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 26 Apr 2023
Reporting date: 25 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-39856

DEFA14A

Filing date: 21 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-39856

DEF 14A

Filing date: 21 Apr 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 20 Apr 2023
Reporting date: 18 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 20 Apr 2023
Reporting date: 18 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 20 Apr 2023
Reporting date: 18 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 20 Apr 2023
Reporting date: 18 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Apr 2023
Reporting date: 12 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Apr 2023
Reporting date: 12 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Mar 2023
Reporting date: 23 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 17 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 09 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 09 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270389

S-8

Filing date: 09 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270387

S-8

Filing date: 09 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-270384

S-3

Filing date: 09 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-39856

10-K

Filing date: 09 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39856

8-K

Filing date: 09 Mar 2023
Reporting date: 09 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2023
Reporting date: 22 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .